ABCC1 and osteosarcoma: In osteosarcoma cells, IL-6 produced by MSCs activates the JAK2/STAT3 signaling, with the subsequent up-regulation of multidrug resistance protein (MRP) and P-gP expression, which is relevant to poor response rates of clinical osteosarcoma chemotherapy (Tu et al., 2016).